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Generally, high testosterone levels within the physiological
range are associated with a more favourable cardiometa-
bolic profile. Although the FDA has approved testosterone
for use only in men with hypogonadism, whose sex glands
produce extremely low amounts of testosterone, off-label
use has dramatically increased in recent years. In the past
two decades, there has been a huge increase in testosterone
prescriptions, and many trials have shown benefit in terms
of risk factor modification and symptoms. These observa-
tions fit also into the picture that reduced testosterone levels
in men are associated with increased cardiovascular risk
inducing elevated triglyceride levels, low high-density
lipoprotein (HDL) cholesterol levels, central obesity,
glucose intolerance, and diabetes. This has recently been
demonstrated by Malkin et al. (October 26 issue, 2010,
Heart), who showed that low testosterone levels (total
testosterone <8.1 nmol/l) are associated with early death in
men with heart disease. The longitudinal follow-up study
involved 930 men with coronary heart disease for a period
of about 7 years. During the study period, 41 of 194 (21%)
men with low testosterone levels died compared with 88 of
736 (12%) men with normal levels of the hormone
(p=0.002). It was concluded that, if androgen deficiency
is part of the underlying pathophysiology of atherosclerotic
disease in men, the serum testosterone level could be
viewed as a favourable modifiable risk factor.
However, this view has been challenged by Basaria et al.
(July 8 issue, 2010, N Engl J Med), who reported that
testosterone is an adverse risk factor for cardiovascular
disease (TOM trial: Testosterone in Older men with
Mobility limitations). The authors showed that more than
20% of men aged 65 and older using testosterone
developed serious cardiovascular problems. The study
included 209 men, who were randomised to placebo or
100 mg testosterone gel once daily for 6 months. Men on
testosterone demonstrated increased strength in leg-press
and chest-press strength and in stair climbing while
carrying a load. However, among the 106 men using
testosterone gel, 23 (22%) had cardiovascular-related
events compared with only 5 of 103 (5%) men of the
placebo group. Compared with the placebo group, men
taking testosterone had a significant increase in haemoglo-
bin and haematocrit levels, and a significant decrease in
HDL cholesterol and LDL cholesterol levels. Because of
the unexpected high rate of adverse cardiac events, the
study was acutely discontinued.
While current discussions did mainly focus on the role of
testosterone and cardiovascular disease in men, the rela-
tionship between testosterone and cardiovascular diseases
may be gender-specific [1–5]. According to a recent study
by Lellamo et al. (October 12 issue, 2010, J Am Coll
Cardiol), application of testosterone may benefit women
with heart failure. Women with systolic heart failure on
low-dose testosterone (300 μg/twice daily) for 6 months, on
top of standard medical therapy, showed significant gains in
exercise and ventilatory capacity and large-muscle strength
along with heightened insulin sensitivity. Testosterone was
applied to 36 elderly women through transdermal patches at
a much lower dosage than are used for testosterone
supplementation in men and produced no apparent andro-
genic or other untoward effects. As a result, testosterone
seems to be an effective and safe therapy for elderly women
with congestive heart failure.
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DOI 10.1007/s12471-010-0058-0To summarise, there are conflicting results on the effects
of testosterone on the cardiovascular system. The role of
testosterone in male cardiovascular health is still not
completely understood as both reduced and increased levels
may result in cardiovascular-related complications. Apart
from that, testosterone may have differential effects in men
and women. Interestingly, application of testosterone seems
to be disadvantageous in men, but beneficial in women.
Many more additional studies are therefore needed to
explain the effect of testosterone on the development of
atherosclerosis. In particular, the gender-specific effects of
testosterone should be thoroughly evaluated.
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